Exelixis: Thyroid Cancer Drug Delays Tumor Growth
TheStreet.com
Biotech Calendar: Key Dates for October
TheStreet.com
Bayer Drug Hailed As Prostate Cancer Game Changer
TheStreet.com
7 Possible Biotech Takeover Targets
Seeking Alpha
Exelixis' Shares Plunged: What You Need to Know
Motley Fool
[video] The Next Big Thing In Biotech: Exelixis
TheStreet.com
Exelixis: Still Promising, Still Controversial
Seeking Alpha

